In a filing, Macrogenics Inc revealed its Senior VP and General Counsel Peters Jeffrey Stuart unloaded Company’s shares for reported $0.8 million on Apr 04 ’24. In the deal valued at $15.55 per share,51,395 shares were sold. As a result of this transaction, Peters Jeffrey Stuart now holds 0 shares worth roughly $0.0.
Then, Peters Jeffrey Stuart sold 19,625 shares, generating $421,938 in total proceeds. Upon selling the shares at $21.50, the Senior VP and General Counsel now owns 8,895 shares.
Before that, Risser Eric Blasius sold 41,159 shares. Macrogenics Inc shares valued at $813,501 were divested by the Chief Operating Officer at a price of $19.76 per share. As a result of the transaction, Risser Eric Blasius now holds 38,900 shares, worth roughly $0.71 million.
BTIG Research reiterated its Macrogenics Inc [MGNX] rating to a Buy in a research note published on March 04, 2024; the price target was $24. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who decreased its forecast for the stock in mid February from “a Buy” to “a Neutral”. Citigroup also remained covering MGNX and has increased its forecast on December 20, 2023 with a “Buy” recommendation from previously “Neutral” rating. Guggenheim revised its rating on November 07, 2023. It rated MGNX as “a Buy” which previously was an “a Neutral”.
Price Performance Review of MGNX
On Monday, Macrogenics Inc [NASDAQ:MGNX] saw its stock jump 0.60% to $18.35. Over the last five days, the stock has gained 30.88%. Macrogenics Inc shares have risen nearly 90.75% since the year began. Nevertheless, the stocks have risen 149.66% over the past one year. While a 52-week high of $21.88 was reached on 03/06/24, a 52-week low of $4.29 was recorded on 01/02/24. SMA at 50 days reached $16.63, while 200 days put it at $9.02. A total of 2.04 million shares were traded, compared to the trading of 1.75 million shares in the previous session.
Levels Of Support And Resistance For MGNX Stock
The 24-hour chart illustrates a support level at 18.00, which if violated will result in even more drops to 17.66. On the upside, there is a resistance level at 18.70. A further resistance level may holdings at 19.06. The Relative Strength Index (RSI) on the 14-day chart is 62.17, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.80, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 10.95%. Stochastics %K at 85.97% indicates the stock is a selling.
How much short interest is there in Macrogenics Inc?
A steep rise in short interest was recorded in Macrogenics Inc stocks on Mar 15, 2024, dropping by -0.78 million shares to a total of 5.6 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 6.38 million shares. There was a decline of -13.93%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 10.94% of the overall stock float, the days-to-cover ratio (short ratio) fell to 2.99.
